Skip to content
Main Navigation
About us
Company profile
Our values
Our strategy
Board of directors
Management
Our history
Innovation and research
Technology platform
Therapeutic areas
Scientific papers and presentations
Pipeline
Partnering
Our approach
Our partnerships
Investors
Financial reports and presentations
Share information
Analyst coverage
Major shareholders
Tax Value per Share
Financial calendar
Corporate governance
Corporate governance statements
ESG
Dividend policy
Annual general meeting
Articles of association
Safe harbour statement
Whistleblower policy
Risk management
Investor relations policy
Email alerting service
Media
News and announcements
Image library
Glossary
Careers
Life at Nykode
Meet us
Open positions
COVID trial
Search
Innovation and research
Scientific papers and presentations
Sharing our discoveries and developments in our tireless pursuit of breakthrough therapies
Newest first
Oldest first
Posters & Papers
Presentations
Search
Reset
21/04/2022
World Vaccine Congress | Using the Vaccibody™ platform to create new second and third generation vaccines against COVID
08/04/2022
2022 AACR | Poster #: 2232 | A novel and versatile cytokine empowered DNA vaccine platform with superior immune activating potential
22/03/2022
Keystone Symposium: Cancer Immunotherapy | Targeting Cancer Antigens to Antigen Presenting Cells to Elicit Rapid, Broad and Dominant CD8 T Cell Responses
08/03/2022
2022 AACR | Abstract #: 2332 | A novel and versatile cytokine empowered DNA vaccine platform with superior immune activating potential
22/07/2021
Using an Inflammatory Chemokine Linked to the Antigen Generates a Rapid, Strong and Broad Immune Response
Pages:
1
2
3
4
5
6
Load more
Sorry, nothing found in this query
Privacy statement
Cookie policy
Disclaimer
